Home Quizzes Quiz Detail
Practice Quiz

ABPath Neuropathology Practice Questions - ABPath Neuropathology Subspecialty Certification Examination Exam

100 questions 5.0 rating Mobile friendly
$69.00

Unlock the full practice quiz

Get complete access to the questions, explanations and printable quiz resources.

Full access: unlock all quiz questions and explanations.
Printable review: access the full quiz PDF with correct answers after purchase.

About this Exam

Prepare with the ABPath Neuropathology Practice Questions - ABPath Neuropathology Subspecialty Certification Examination Exam practice quiz. This question bank includes 100 questions covering shows, year-old, diagnosis, tumor, and biopsy. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

Sample Questions

Question 1
A 42-year-old woman presents with a new-onset seizure. MRI shows a non-enhancing, T2-hyperintense, infiltrative mass in the right frontal lobe. Biopsy shows a moderately cellular astrocytic neoplasm with atypia but no microvascular proliferation or necrosis. IHC shows IDH1 R132H positive and ATRX loss. 1p/19q is retained. Which diagnosis per WHO CNS 2021 is most appropriate?
Astrocytoma, IDH-mutant, CNS WHO grade 2
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, CNS WHO grade 2
Glioblastoma, IDH-wildtype, CNS WHO grade 4
Diffuse midline glioma, H3 K27-altered
Question 2
A 55-year-old man has a left frontal cortical tumor with calcifications on CT. Histology shows monotonous round cells with perinuclear halos ('fried egg'), chicken-wire capillaries, and microcalcifications. Molecular testing shows IDH1 mutation and 1p/19q codeletion. Which diagnosis is correct?
Astrocytoma, IDH-mutant
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Glioblastoma, IDH-wildtype
Central neurocytoma
Question 3
A 65-year-old man has a rapidly growing, ring-enhancing right temporal mass. Biopsy shows a highly cellular astrocytic tumor with microvascular proliferation, pseudopalisading necrosis, and brisk mitoses. IDH1/2 are wild-type. Which molecular finding is sufficient by WHO CNS 2021 criteria to classify this as glioblastoma, IDH-wildtype grade 4, even without necrosis or microvascular proliferation?
ATRX loss
TERT promoter mutation, EGFR amplification, or +7/-10 chromosome signature
MGMT promoter methylation
BRAF V600E mutation
Question 4
A 9-year-old child has a midline pontine infiltrative tumor. Biopsy shows a high-grade diffuse astrocytic neoplasm. IHC shows loss of H3 K27me3 and positivity for H3 K27M. This defines which WHO CNS 2021 entity?
Pilocytic astrocytoma
Diffuse midline glioma, H3 K27-altered, CNS WHO grade 4
Diffuse hemispheric glioma, H3 G34-mutant
Medulloblastoma, SHH-activated
Question 5
A 22-year-old presents with a hemispheric high-grade glioma. Sequencing shows H3.3 G34R mutation with ATRX loss and TP53 mutation. Which WHO CNS 2021 tumor is this?
Diffuse midline glioma, H3 K27-altered
Diffuse hemispheric glioma, H3 G34-mutant, CNS WHO grade 4
Infant-type hemispheric glioma
Glioblastoma, IDH-wildtype

Ready to test your knowledge?

Buy Now to Access

Additional Information

ABPath Neuropathology Practice Questions - ABPath Neuropathology Subspecialty Certification Examination Exam

This practice set contains 100 questions from the matching question bank and focuses on shows, year-old, diagnosis, tumor, and biopsy. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Frequently Asked Questions

This quiz contains a total of 100 practice questions carefully selected to test your knowledge on this subject.
Yes, you will have exactly 0 minutes to complete the exam. A countdown timer will be visible once you start.
Yes, you can retake this practice test as many times as you need. The questions and options may be randomized on subsequent attempts to ensure comprehensive learning.

Reviews

5.0

Based on 0 reviews

Leave a Review

No reviews yet. Be the first to review!